estropipate
Estropipate is a medication used to treat Hypogonadism, Menopause, Premature Menopause, Menorrhagia.
Generic · by Watson Labs Teva
Key facts
- Active ingredient
- Estropipate
- Form
- Tablet
- Strength
- Estropipate 3MG
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- May treat
- hypogonadism, menopause, premature menopause
- Manufacturer
- Watson Labs Teva
- FDA application
- ANDA081215
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Estropipate treat?
- Estropipate (Estropipate) may be used to treat hypogonadism, menopause, premature menopause, menorrhagia, primary ovarian insufficiency, hot flashes, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Estropipate?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Estropipate. To pay less, Estropipate is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Estropipate?
- Estropipate is marketed by Watson Labs Teva. You can see Watson Labs Teva's full profile, rating, and other products on pharmaranks.
- Is Estropipate a brand-name or generic drug?
- Estropipate is a generic medication; its active ingredient is Estropipate. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Estropipate available over the counter?
- No. Estropipate is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Estropipate come in?
- Estropipate is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Estropipate FDA-registered?
- Estropipate is on record with the U.S. FDA under application number ANDA081215. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about Estropipate
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 951 reports naming Estropipate, and the FDA flagged 71% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- breast cancer female181 reports
- breast cancer138 reports
- nausea50 reports
- headache38 reports
- fatigue37 reports
- anxiety33 reports
- dizziness32 reports
- insomnia32 reports
Read these as a signal, not a rate. A report does not mean Estropipate caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
azmiro
Testosterone Cypionate
elestrin
Estradiol
imvexxy
Estradiol
jatenzo
Testosterone Undecanoate
veozah
Fezolinetant
evamist
Estradiol
Compare Estropipate head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
estropipate
New